ロード中...
Effect of ADMA levels on severity of erectile dysfunction in chronic kidney disease and other risk factors
INTRODUCTION: Hormonal, neurogenic, vasculogenic, and psychogenic impairments, as well as endothelial dysfunction may play a role in erectile dysfunction (ED) in patients with chronic kidney disease (CKD). Asymmetrical dimethylarginine (ADMA) is an inhibitor of nitric oxide, which is the key element...
保存先:
| 出版年: | Can Urol Assoc J |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Canadian Medical Association
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4729575/ https://ncbi.nlm.nih.gov/pubmed/26858787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.3170 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|